DK1192152T3 - Fluorerede benzodioxanimidazolinderivater, deres fremstilling og terapeutisk anvendelse - Google Patents
Fluorerede benzodioxanimidazolinderivater, deres fremstilling og terapeutisk anvendelseInfo
- Publication number
- DK1192152T3 DK1192152T3 DK00949575T DK00949575T DK1192152T3 DK 1192152 T3 DK1192152 T3 DK 1192152T3 DK 00949575 T DK00949575 T DK 00949575T DK 00949575 T DK00949575 T DK 00949575T DK 1192152 T3 DK1192152 T3 DK 1192152T3
- Authority
- DK
- Denmark
- Prior art keywords
- preparation
- fluorinated
- derivatives
- benzodioxanimidazoline
- therapeutic use
- Prior art date
Links
- 230000001225 therapeutic effect Effects 0.000 title abstract 2
- GOXQDKOVCYSWJU-UHFFFAOYSA-N 2,3-dihydro-1,4-benzodioxine;4,5-dihydro-1h-imidazole Chemical class C1CN=CN1.C1=CC=C2OCCOC2=C1 GOXQDKOVCYSWJU-UHFFFAOYSA-N 0.000 abstract 1
- 125000003342 alkenyl group Chemical group 0.000 abstract 1
- 125000000217 alkyl group Chemical group 0.000 abstract 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 229910052731 fluorine Inorganic materials 0.000 abstract 1
- 125000001153 fluoro group Chemical group F* 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Psychology (AREA)
- Virology (AREA)
- Hospice & Palliative Care (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- Vascular Medicine (AREA)
- Communicable Diseases (AREA)
- Urology & Nephrology (AREA)
- AIDS & HIV (AREA)
- Pain & Pain Management (AREA)
- Oncology (AREA)
- Physical Education & Sports Medicine (AREA)
- Gynecology & Obstetrics (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9908302A FR2795727B1 (fr) | 1999-06-29 | 1999-06-29 | Nouveaux derives benzodioxanne imidazolines fluores, leur preparation et leurs applications en therapeutique |
PCT/FR2000/001825 WO2001000619A1 (fr) | 1999-06-29 | 2000-06-29 | Nouveaux derives benzodioxanne imidazolines fluores, leur preparation et leurs applications en therapeutique |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1192152T3 true DK1192152T3 (da) | 2003-03-17 |
Family
ID=9547432
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK00949575T DK1192152T3 (da) | 1999-06-29 | 2000-06-29 | Fluorerede benzodioxanimidazolinderivater, deres fremstilling og terapeutisk anvendelse |
Country Status (16)
Country | Link |
---|---|
US (1) | US6610725B1 (es) |
EP (1) | EP1192152B1 (es) |
JP (1) | JP4608160B2 (es) |
CN (1) | CN1139588C (es) |
AT (1) | ATE228516T1 (es) |
AU (1) | AU778796B2 (es) |
BR (1) | BR0012042A (es) |
CA (1) | CA2377186A1 (es) |
DE (1) | DE60000880T2 (es) |
DK (1) | DK1192152T3 (es) |
ES (1) | ES2186654T3 (es) |
FR (1) | FR2795727B1 (es) |
MX (1) | MXPA02000256A (es) |
PT (1) | PT1192152E (es) |
WO (1) | WO2001000619A1 (es) |
ZA (1) | ZA200200009B (es) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB0117645D0 (en) | 2001-07-19 | 2001-09-12 | Isis Innovation | Therapeutic stratergies for prevention and treatment of alzheimers disease |
US8188126B2 (en) | 2002-05-16 | 2012-05-29 | Pierre Fabre Medicament | Imidazolic compounds and use thereof as alpha-2 adrenergic receptors |
JP4604583B2 (ja) * | 2004-07-20 | 2011-01-05 | ダイソー株式会社 | 1−アミド−3−(2−ヒドロキシフェノキシ)−2−プロパノール誘導体、ならびに2−アミドメチル−1,4−ベンゾジオキサン誘導体の製造法 |
US8580776B2 (en) * | 2007-07-10 | 2013-11-12 | The Board Of Trustees Of The University Of Illinois | Compositions and methods for treating neurodegenerating diseases |
US20110165037A1 (en) * | 2010-01-07 | 2011-07-07 | Ismagilov Rustem F | Interfaces that eliminate non-specific adsorption, and introduce specific interactions |
JP2019519582A (ja) * | 2016-06-29 | 2019-07-11 | オリオン コーポレーション | ベンゾジオキサン誘導体およびその医薬用途 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PH16249A (en) * | 1980-02-04 | 1983-08-16 | Reckitt & Colmann Prod Ltd | Imidazoline derivatives,its pharmaceutical composition and method of use |
NZ203680A (en) * | 1982-04-17 | 1985-08-16 | Reckitt & Colmann Prod Ltd | Imidazolines and pharmaceutical compositions |
-
1999
- 1999-06-29 FR FR9908302A patent/FR2795727B1/fr not_active Expired - Fee Related
-
2000
- 2000-06-29 DK DK00949575T patent/DK1192152T3/da active
- 2000-06-29 US US10/019,614 patent/US6610725B1/en not_active Expired - Lifetime
- 2000-06-29 EP EP00949575A patent/EP1192152B1/fr not_active Expired - Lifetime
- 2000-06-29 PT PT00949575T patent/PT1192152E/pt unknown
- 2000-06-29 AT AT00949575T patent/ATE228516T1/de not_active IP Right Cessation
- 2000-06-29 BR BR0012042-1A patent/BR0012042A/pt not_active Application Discontinuation
- 2000-06-29 WO PCT/FR2000/001825 patent/WO2001000619A1/fr active IP Right Grant
- 2000-06-29 MX MXPA02000256A patent/MXPA02000256A/es active IP Right Grant
- 2000-06-29 CA CA002377186A patent/CA2377186A1/fr not_active Abandoned
- 2000-06-29 CN CNB008106223A patent/CN1139588C/zh not_active Expired - Fee Related
- 2000-06-29 JP JP2001507027A patent/JP4608160B2/ja not_active Expired - Fee Related
- 2000-06-29 AU AU62890/00A patent/AU778796B2/en not_active Ceased
- 2000-06-29 ES ES00949575T patent/ES2186654T3/es not_active Expired - Lifetime
- 2000-06-29 DE DE60000880T patent/DE60000880T2/de not_active Expired - Lifetime
-
2002
- 2002-01-02 ZA ZA200200009A patent/ZA200200009B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
DE60000880T2 (de) | 2003-08-28 |
FR2795727A1 (fr) | 2001-01-05 |
CN1139588C (zh) | 2004-02-25 |
PT1192152E (pt) | 2003-04-30 |
AU6289000A (en) | 2001-01-31 |
ZA200200009B (en) | 2002-09-25 |
CN1361776A (zh) | 2002-07-31 |
CA2377186A1 (fr) | 2001-01-04 |
JP2003503406A (ja) | 2003-01-28 |
AU778796B2 (en) | 2004-12-23 |
JP4608160B2 (ja) | 2011-01-05 |
MXPA02000256A (es) | 2002-06-21 |
WO2001000619A1 (fr) | 2001-01-04 |
EP1192152B1 (fr) | 2002-11-27 |
US6610725B1 (en) | 2003-08-26 |
ES2186654T3 (es) | 2003-05-16 |
DE60000880D1 (de) | 2003-01-09 |
EP1192152A1 (fr) | 2002-04-03 |
FR2795727B1 (fr) | 2001-09-21 |
BR0012042A (pt) | 2002-07-09 |
ATE228516T1 (de) | 2002-12-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE0104334D0 (sv) | Therapeutic agents | |
ES2059069T3 (es) | Nuevos derivados de 1-alcoxi-(2-acilamino-etil)-naftalenos y su procedimiento de preparacion. | |
ES2121441T3 (es) | Nuevos derivados de 3,5 -dioxo - (2h,4h) - 1,2,4 - triazina,su preparacion y aplicacion como farmaco | |
ATE68473T1 (de) | 1-phenyl-3-naphthalenyloxy-propanamine. | |
ID26622A (id) | Senyawa-senyawa pengganti 2-benzylamino-2-phenyl-acetamide | |
TW429255B (en) | Pyrazine compounds having treatment of central nervous system diseases and disorders | |
AP9901578A0 (en) | Sulfonylbenzene compounds as anti-inflammatory/analgesic agents. | |
DK1192152T3 (da) | Fluorerede benzodioxanimidazolinderivater, deres fremstilling og terapeutisk anvendelse | |
ES8606337A1 (es) | Un procedimiento para preparar nuevas benzamidas con actividada antagonista de 5-ht. | |
NZ221699A (en) | Pyridazinone derivatives; pharmaceutical compositions and intermediates | |
DK0484378T3 (da) | Antiarytmiske tertiær amin-alkenyl-phenyl-alkansulfonamider | |
ES2064057T3 (es) | Unos derivados de 2-(aminoalquil)-5-(arilalquil)-1,3-dioxanos, su preparacion y su aplicacion en terapeutica. | |
ES2062792T3 (es) | Acidos dihidrobenzopiran-2-carboxilicos alcoxi-sustituidos y derivados de los mismos. | |
ES8707951A1 (es) | Derivados de tetrazol | |
DK0765323T3 (da) | 4-(6-fluor-1,2-benzisoxazolyl)-1-piperidinylpropoxychromen-4-onderivater, deres fremstilling og deres anvendelse til behandling af psykose, skizofreni og angst | |
ATE122683T1 (de) | Epoxybernsteinsäurederivate, verwendbar als spezifische hemmer von cathepsin b. | |
DE60004669D1 (de) | Indolocarbazolalkaloide aus einer marinen actinomycete | |
DE69219219D1 (de) | Verwendung von 3-Pyridazinone zur Verringerung der Blutplätchenzahl | |
DK0520882T3 (da) | Derivater af 2-aminopyrimidin-4-carboxamid, deres fremstilling og deres terapeutiske anvendelse | |
ATE66475T1 (de) | Aromatische thioaether. | |
DK0707587T3 (da) | Farmakologisk aktive enantiomerer | |
PT86852A (pt) | Procede de preparation des nouveaux acetamides derives de la dihydro-2,3 phenyl-3 benzofurannone-2 | |
DE60239324D1 (de) | Phenyl- und pyridyl-piperidine mit tnf-wirkung | |
DE3782229D1 (de) | Verwendung von 2-oxo-imidazolidin-derivaten zur behandlung von nierenkrankheiten. |